Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Drosophila Study Sheds Light on Metastatic Behavior of Human Tumors

By Institute for Research in Biomedicine | September 28, 2018

Metastatic tumors are characterized by a high degree of chromosomal instability—that is to say a constant change in the number and structure of chromosomes they hold. In spite of this observation, it is unknown whether chromosomal instability contributes to the metastatic process. A study at the Institute for Research in Biomedicine (IRB Barcelona) using Drosophila melanogaster has demonstrated that chromosomal instability itself can induce invasive behavior in epithelial cells and has identified the underlying molecular mechanisms involved.

To perform this study, the team directed by ICREA researcher Marco Milán generated a fruit fly model with chromosomal instability. “The cells started to actively invade adjacent tissues,” explains Marco Milán, group leader of the Growth Control and Development lab at IRB Barcelona and head of the study.

The aim was to study whether chromosomal instability itself has the capacity to stimulate invasive behavior in epithelial cells. The results published in Developmental Cell indicate that indeed this is the case and they describe a series of molecular and cell mechanisms that favour cell migration and invasion of other tissues. In particular, the researchers have demonstrated that invasive cells use the actin cytoskeleton and activate the ERK and JNK signalling pathways to trigger a pro-invasive transcriptional programme executed by the oncogene Fos and repressed by the tumor suppressor Capicua.

“These findings are relevant in the context of cancer because they highlight the causal relationship between aneuploid genomes and cell invasion and they identify the molecular elements involved in the process,” say Najate Benhra and Lara Barrio, first authors of the study and postdoctoral researchers at IRB Barcelona. Milán adds, “the results increase our understanding of the effects of chromosomal instability on the metastatic potential of solid human tumors and identify molecular targets for the development of future treatments.”

This research has been funded by the Ministry of Science, Innovation and Universities.

SOURCE: Institute for Research in Biomedicine


Filed Under: Oncology

 

Related Articles Read More >

AstraZeneca/Daiichi-Sankyo
FDA approves Enhertu for HER2-low breast cancer
ChemoCentryx/Amgen
Amgen to pay almost $4B for ChemoCentryx
Olema Oncology
Olema Oncology’s OP-1250 could be a game-changing breast cancer drug
Merck in the Drug Discovery & Development Pharma 50
Merck halts Phase 3 Lynparza for futility

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50